Attentional effects of nicotinic agonists in rats

[1]  B. Hahn,et al.  Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement , 2002, Behavioural pharmacology.

[2]  B. Hahn,et al.  Nicotine-induced Attentional Enhancement in Rats: Effects of Chronic Exposure to Nicotine , 2002, Neuropsychopharmacology.

[3]  S. Wonnacott,et al.  Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165. , 2002, Journal of medicinal chemistry.

[4]  M. Shoaib,et al.  Nicotine-induced enhancement of attention in the five-choice serial reaction time task: the influence of task demands , 2002, Psychopharmacology.

[5]  G. Higgins,et al.  A study of the nicotinic agonist SIB-1553A on locomotion, and attention as measured by the five-choice serial reaction time task , 2001, Pharmacology Biochemistry and Behavior.

[6]  S. Wonnacott,et al.  Differential effects of chronic drug treatment on α3* and α7 nicotinic receptor binding sites, in hippocampal neurones and SH‐SY5Y cells , 2001 .

[7]  G. Higgins,et al.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task , 2000, Behavioural Brain Research.

[8]  J. Macor,et al.  (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. , 2000, Journal of medicinal chemistry.

[9]  A. C. Collins,et al.  UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes , 2000, The Journal of Neuroscience.

[10]  D. Sanger,et al.  Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies , 2000, Psychopharmacology.

[11]  G. Chiara.  Role of dopamine in the behavioural actions of nicotine related to addiction. , 2000 .

[12]  E. Levin,et al.  AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats , 1999 .

[13]  J P Changeux,et al.  International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. , 1999, Pharmacological reviews.

[14]  T. Robbins,et al.  Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat , 1999, Neuroscience.

[15]  B. Potter,et al.  Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors , 1999, Neuropharmacology.

[16]  E. Levin,et al.  Transdermal nicotine effects on attention , 1998, Psychopharmacology.

[17]  Ian P. Stolerman,et al.  Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.

[18]  A. Lawrence,et al.  The Cognitive Psychopharmacology of Alzheimer's Disease: Focus on Cholinergic Systems , 1998, Neurochemical Research.

[19]  T. Lewis,et al.  The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type , 1997, The Journal of physiology.

[20]  R. Papke,et al.  Activation and inhibition of rat neuronal nicotinic receptors by ABT‐418 , 1997, British journal of pharmacology.

[21]  E. Levin,et al.  Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.

[22]  K. Keyser,et al.  Assembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits* , 1996, The Journal of Biological Chemistry.

[23]  I. Stolerman,et al.  The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens. , 1996, European journal of pharmacology.

[24]  I. Stolerman,et al.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats , 1995, British journal of pharmacology.

[25]  R Anand,et al.  Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. , 1995, Molecular pharmacology.

[26]  M. Aceto,et al.  Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist , 1995, Psychopharmacology.

[27]  W. J. Jackson,et al.  Isoarecolone‐induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors , 1995, Neuroreport.

[28]  J. Muir,et al.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron , 1995, Psychopharmacology.

[29]  A. D. Rodrigues,et al.  Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease , 1995 .

[30]  M. Damaj,et al.  Pharmacological effects of epibatidine optical enantiomers , 1994, Brain Research.

[31]  D. Donnelly-roberts,et al.  (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[32]  D. Donnelly-roberts,et al.  (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. , 1994, The Journal of pharmacology and experimental therapeutics.

[33]  R Anand,et al.  Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. , 1994, Molecular pharmacology.

[34]  R. Lukas,et al.  Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line , 1993, Molecular and Cellular Neuroscience.

[35]  J. Patrick,et al.  Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  Trevor W. Robbins,et al.  Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal , 1989, Behavioural Brain Research.

[37]  T. Robbins,et al.  Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal , 1983, Behavioural Brain Research.

[38]  P. Clarke,et al.  The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats , 1983, British journal of pharmacology.

[39]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[40]  E. Levin,et al.  Nicotine effects on adults with attention-deficit/hyperactivity disorder , 2005, Psychopharmacology.

[41]  P. Tariot,et al.  Intravenous nicotine in Alzheimer's disease: a pilot study , 2004, Psychopharmacology.

[42]  S. Wonnacott,et al.  Neuronal nicotinic receptors , 2001 .

[43]  W. J. Jackson,et al.  Central nicotinic receptor agonists ABT-418, ABT-089, and (–)-nicotine reduce distractibility in adult monkeys , 1998, Psychopharmacology.

[44]  S. Heinemann,et al.  Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. , 1994, Molecular pharmacology.